Dr. Chetan Naik, MD

Claim this profile

Baylor University Medical Center

Studies Bronchiolitis
Studies Bronchiolitis Obliterans
4 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Baylor University Medical Center

More about Chetan Naik, MD

Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Chetan Naik, MD has experience with
  • Liposomal Cyclosporine A
  • Standard Of Care
  • Extracorporeal Photopheresis (ECP)
  • AV-101

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chetan Naik, MD specialize in?
Chetan Naik, MD focuses on Bronchiolitis and Bronchiolitis Obliterans. In particular, much of their work with Bronchiolitis has involved treating patients, or patients who are undergoing treatment.
Is Chetan Naik, MD currently recruiting for clinical trials?
No, Chetan Naik, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Chetan Naik, MD has studied deeply?
Yes, Chetan Naik, MD has studied treatments such as Liposomal Cyclosporine A, Standard of Care, Extracorporeal Photopheresis (ECP).
What is the best way to schedule an appointment with Chetan Naik, MD?
Apply for one of the trials that Chetan Naik, MD is conducting.
What is the office address of Chetan Naik, MD?
The office of Chetan Naik, MD is located at: Baylor University Medical Center, Dallas, Texas 75246 United States. This is the address for their practice at the Baylor University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.